Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Stop-Loss Cost-Sharing Proposed By Thomas

Executive Summary

The federal government and private insurers could share the cost of providing Medicare prescription drug stop-loss insurance as an alternative to a "risk pool" approach, Rep. Thomas said March 28 in a speech to the Federation of American Health Systems.

You may also be interested in...



PBMs Must Use "Aggressive" Rx Cost Containment In Medicare - Rep. Thomas

Discussions about the structure of competition under a pharmacy benefit management company administered Medicare drug benefit are irrelevant if PBMs are not able to pursue "aggressive" cost containment, House Ways & Means/Health Subcommittee Chairman Thomas (R-Calif.) said during a May 11 hearing.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

PS142351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel